Dr Gerry Thompson

Senior Clinical Lecturer in Radiology, The University of Edinburgh

Gerry Thompson is a Senior Clinical Lecturer in Radiology at the University of Edinburgh and an Honorary Consultant Neuroradiologist in the NHS Lothian Department of Clinical Neurosciences providing specialist neuro-oncology imaging diagnostics for South East Scotland. He trained in Radiology and Neuroradiology in the North West of England, completing a PhD in quantitative imaging biomarkers in glioma at the University of Manchester in 2012, before taking up an academic consultant post in Edinburgh in 2016. Gerry is Co-Director (Neuro) for the University of Edinburgh/NHS Lothian Clinical Research Facility Image Analysis Core which provides imaging support for academic studies and clinical trials. His main research interests cover quantitative neuroimaging with MRI and PET, and studies into optimising timing of studies in brain tumour follow-up. He is the imaging co-lead for the multicentre Tessa Jowell Brain MATRIX clinical trial platform, and imaging lead for the multicentre NIHR-funded SPRING (seizure prophylaxis in glioma) clinical trial. He is the Edinburgh PI for the multicentre DIG (Diffusion in Glioma) study and provides local Radiological expert assessments for several international neuro-oncology clinical trials. His multicentre projects include streamlining image-based response assessments through RANO, and development of machine learning and artificial intelligence tools to quantitatively assess radiomics and response in multicentre imaging data and integrating this with non-imaging data, particularly those coming through heterogeneous standard of care pathways. Gerry is a current member of the NCRI Brain Glioma Subgroup, and sits on the Scientific Advisory Board of the Brain Tumour Charity. He engages directly with patients and carers to provide insights and education into the role of imaging in brain tumour management through seminars organised and delivered through Brainstrust.

Gerry’s quantitative biomarker discovery research involves combining multimodality cross sectional imaging including novel contrast agents and tracers with histology and spatially-resolved phenomics. This includes extensive translational work having recently co-founded ENTIRe (Edinburgh Neuro-oncology Translational Imaging Research) in the Centre for Clinical Brain Sciences and ALLMoND (Academic Led Large animal Models of Neurological Disorders) in the Roslin Institute. He is the neuroimaging member on the Large Animal Steering Group at the Roslin Institute and is the Clinical Imaging Adviser for the recently completed £25M Large Animal Research and Imaging Facility (LARIF).

Gerry aims to provide more useful, actionable, individualised insights into brain tumour diagnosis and response through making best use of available imaging tools, and developing novel techniques to address unmet needs such as bespoke treatment selection and robustly differentiating tumour treatment response from progression.

Back to Speakers


BNOS @BNOSOfficial   3:38 PM - Fri 9 Apr 2021

Super sponsorship opportunities for #BNOS2021 https://t.co/2KOJbAHELU

BNOS @BNOSOfficial   3:39 PM - Wed 7 Apr 2021

📢Great news for people who prefer to use Facebook!👏 You can now follow / like @BNOSofficial here! https://t.co/elFPq8rhyp

BNOS @BNOSOfficial   10:53 AM - Fri 2 Apr 2021

Happy Good Friday to all! Looking forward to meeting you at our💻virtual Conference in July! 👀 register here: ✍️https://t.co/0sbI3UTD5X https://t.co/KqGd9X75HR

BNOS @BNOSOfficial   12:54 PM - Thu 1 Apr 2021

@BNOSoffical @theIBTA March Newsletter is out and can be read here: 👀🧠 https://t.co/HfLcrbA6Om

BNOS @BNOSOfficial   3:18 PM - Tue 30 Mar 2021

Andrew Peet is a valued member of @BNOSofficial Council too! 🧠👏 https://t.co/bYpGRiEoXf

BNOS @BNOSOfficial   5:12 PM - Mon 29 Mar 2021


BNOS @BNOSOfficial   1:29 PM - Sun 28 Mar 2021

📢 Don't delay, get your fabulous research to us today! Midnight Deadline! ⏳ Abstracts can be submitted online at https://t.co/gDhKyEOOGF